Phoenix Biotech Acquisition Corp.

NASDAQ: PBAX · Real-Time Price · USD
5.85
0.37 (6.75%)
At close: Feb 14, 2024, 8:56 PM

Phoenix Biotech Acquisition Revenue

Phoenix Biotech Acquisition reported an annual revenue of $254.83K, reflecting a 0% growth. For the quarter ending September 30, 2023, Phoenix Biotech Acquisition generated $0 in revenue.
Revenue (ttm)
$254.83K
Revenue Growth
0%
Price / Sales Ratio
721.25
Revenue / Employee
-
Employees
undefined
Market Cap
36.47M

Revenue Chart

Created with Highcharts 11.4.300254.83K254.83K202120220100K200K300K

Phoenix Biotech Acquisition Revenue - Annual

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2022 254.83K +Infinity%
Dec 31, 2021 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.